UOLGF yields 1.66% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, UOLGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UOLGF + JNJ for your $10,000?
UOL Group Limited primarily engages in property development and investment, and hotel businesses. Its property development projects include residential units, commercial offices, shopping malls, and hotels and serviced suites. The company also owns and/or manages approximately 30 hotels, resorts, and services suites under the Pan Pacific, PARKROYAL COLLECTION, and PARKROYAL brands in Asia, Oceania, and North America with approximately 10,000 rooms in its portfolio. In addition, it is involved in the rental and management of serviced suites; leasing of commercial properties and serviced suites; operation of restaurants; and management and operation of health and beauty retreats and facilities. Further, the company engages in the retail of computer hardware and software, as well as provision of systems integration and networking infrastructure services; property trading business; management and licensing of trademarks; and business development activity. Additionally, it provides treasury, retail management consultancy, project and property management, property management agency, and trustee services; technical, accounting, administrative, and marketing and related services to hotels and serviced suites; and information technology-related products and services, as well as invests in quoted and unquoted financial assets. It has operations in Singapore, Australia, Vietnam, Malaysia, the People's Republic of China, Myanmar, the United Kingdom, and internationally. The company was formerly known as United Overseas Land Limited and changed its name to UOL Group Limited in 2006. UOL Group Limited was incorporated in 1963 and is based in Singapore.
Full UOLGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.